Circulating GPER-1, 8-Iso-Prostaglandin F2α, and Raftlin-1 in Hypertensive Women During the Menopausal Transition: Associations with BMI and Diagnostic Performance
Journal of Clinical Medicine · 10.06.2026 · 15 (12) · 4484
DOI: 10.3390/jcm15124484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.06.2026. Verfasst von Ünal Öztürk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Medical Faculty, Kahramanmaraş Sütçü İmam University, 46050 Kahramanmaraş, Turkey. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hypertension (HTN) is a multifactorial condition involving alterations in vascular signaling, inflammation, and oxidative stress. Women during the menopausal transition may experience increased cardiovascular risk due to hormonal fluctuations, highlighting the need for circulating biomarkers that may assist in identifying HTN-related biological changes. This study aimed to evaluate circulating biomarkers reflecting estrogen signaling, inflammation, and oxidative stress, and to assess their diagnostic accuracy in HTN.
Methods
This cross-sectional study included 54 treatment-naïve hypertensive women and 30 age-matched normotensive controls, all in the menopausal transition period. Serum levels of GPER-1, 8-iso-PGF2α, raftlin-1, and estradiol were measured using ELISA. Associations between biomarkers and body mass index (BMI) were examined using Spearman correlation. Diagnostic discrimination was examined using ROC curve analysis, and optimal cut-off points were determined using the Youden index.
Results
Serum levels of GPER-1, 8-iso-PGF2α, and raftlin-1 were significantly higher in the HTN group compared to controls, while estradiol showed a modest increase. No significant associations were found between BMI and any of the measured biomarkers within the HTN group. ROC analysis demonstrated that 8-iso-PGF2α and raftlin-1 showed the highest diagnostic accuracy for distinguishing HTN patients from controls, followed by GPER-1, whereas estradiol showed limited diagnostic value. High sensitivity and specificity values further supported the diagnostic potential of 8-iso-PGF2α and raftlin-1.
Conclusions
These findings suggest that serum raftlin-1 and 8-iso-PGF2α levels may serve as potential biomarkers for distinguishing hypertension in women during the menopausal transition, while GPER-1 also demonstrated good diagnostic accuracy. The lack of association with BMI suggests relative independence from adiposity-related effects. However, further validation in larger and well-characterized cohorts is required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Medical Faculty, Kahramanmaraş Sütçü İmam University, 46050 Kahramanmaraş, Turkey.
- Department of Medical Biochemistry, Medical Faculty, Kahramanmaraş Sütçü İmam University, 46050 Kahramanmaraş, Turkey.
Zitieren
APA
Öztürk, Ü., Üremiş, M. M., & Kurutaş, E. B. (2026). Circulating GPER-1, 8-Iso-Prostaglandin F2α, and Raftlin-1 in Hypertensive Women During the Menopausal Transition: Associations with BMI and Diagnostic Performance. Journal of Clinical Medicine, 15(12), 4484. https://doi.org/10.3390/jcm15124484
Vancouver
Öztürk Ü, Üremiş MM, Kurutaş EB. Circulating GPER-1, 8-Iso-Prostaglandin F2α, and Raftlin-1 in Hypertensive Women During the Menopausal Transition: Associations with BMI and Diagnostic Performance. Journal of Clinical Medicine. 2026;15(12):4484. doi:10.3390/jcm15124484
BibTeX
@article{ztrk2026,
author = {Öztürk, Ünal and Üremiş, Muhammed Mehdi and Kurutaş, Ergül Belge},
title = {Circulating GPER-1, 8-Iso-Prostaglandin F2α, and Raftlin-1 in Hypertensive Women During the Menopausal Transition: Associations with BMI and Diagnostic Performance},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4484},
doi = {10.3390/jcm15124484}
}
EUVIMED